(Q48443382)

English

Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat.

scientific article published in May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9593857

Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9593857

author name string

Fisher A

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9593857

Biggs CS

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9593857

Starr MS

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9593857

language of work or name

0 references

publication date

1 May 1998

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9593857

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9593857

792

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9593857

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9593857

126-132

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9593857

The behavioral effects of MK-801 injected into nucleus accumbens and caudate-putamen of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Dextromethorphan and parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Motor actions of eliprodil in the normal and monoamine-depleted mouse: a role in the treatment of Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Marked locomotor stimulation in monoamine-depleted mice following treatment with atropine in combination with clonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Opposite presynaptic regulations by glutamate through NMDA receptors of dopamine synthesis and release in rat striatal synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Differential regulation by N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors of acetylcholine release from the rat striatum in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Dizocilpine enhances striatal tyrosine hydroxylase and aromatic L-amino acid decarboxylase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Presynaptic inhibition by clonidine of neurotransmitter amino acid release in various brain regions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Role of D1 receptor mechanisms in the potentiation of motor responses to L-dopa and apomorphine by MK 801 in the reserpine-treated mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Antiparkinsonian action of dextromethorphan in the reserpine-treated mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Glutamatergic drugs in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

The receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Dextromethorphan blocks N-methyl-D-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of L-dihydroxyphenylalanine in the "hemiparkinsonian" rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via nondopaminergic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Microdialysis evidence that acetylcholine in the nucleus accumhens is involved in morphine withdrawal and its treatment with clonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Modulation of retinal aromatic L-amino acid decarboxylase via alpha 2 adrenoceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Behavioural effects of N-methyl-D-aspartate in the anterodorsal striatum of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Antiparkinsonian actions of glutamate antagonists--alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Injection of the competitive NMDA receptor antagonist AP-5 into the nucleus accumbens of monoamine-depleted mice induces pronounced locomotor stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Dextromethorphan and neuromodulation: old drug coughs up new activities

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Glutamatergic control over brain dopamine release in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Regulation of aromatic L-amino acid decarboxylase by dopamine receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Aromatic l-amino acid decarboxylase: Biological characterization and functional role

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900129-2

7 January 2021

Identifiers

10.1016/S0006-8993(98)00129-2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9593857

release_oq3g3cb3nfgohjx3gqiac5wfgm

1 reference

https://api.fatcat.wiki/v0/release/oq3g3cb3nfgohjx3gqiac5wfgm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9593857

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48443382&oldid=1950352184"